跳至主要内容
临床试验/CTRI/2022/11/046943
CTRI/2022/11/046943招募中不适用

Use of Ivabradine for Attenuation of Stressor Response following Laryngoscopy and Intubation in patient undergoing surgery under general anaesthesia in tertiary care hospital: a double blind placebo controlled randomized trial.

SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年1月11日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
the change in heart rate, blood

研究概览

简要总结

Patients undergoing elective surgical procedure under general anaesthesia

during the study period will be the population group. the study population will receive tab Ivabradine 1 hr before induction of anesthesia and hemodynamic parameter will be measured on specific time period.Research is still going on to evaluate the effectiveness of oral ivabradine in maintenance of hemodynamic stability.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • All American Society of Anaesthesiology (ASA) physical status I, aged 18- 50 yrs posted for elective non cardiac surgery under general anaesthesia requiring endotracheal intubation who consent to be part of the study.

排除标准

  • Patient not giving consent for the study.
  • ASA status >II 6
  • Anticipated difficult intubation(Mallampati Class III and IV, thyromental height < 6 cm , inter-incisor distance <3cm and cervical instability.
  • Baseline BP <90/50mm Hg (65) or >140/85mm Hg (105)
  • History of syncope, palpitation, chest pain or cardiac/ respiratory illness, liver or renal dysfunction.
  • History of substance abuse.
  • Those with ECG abnormalities.

结局指标

主要结局

the change in heart rate, blood

时间窗: 24 hours of total study duration in each case starting from the oral intake of study drug.

pressure and MAP (mean arterial pressure) following laryngoscopy and

时间窗: 24 hours of total study duration in each case starting from the oral intake of study drug.

intubation, which shall be compared between the study and control group.

时间窗: 24 hours of total study duration in each case starting from the oral intake of study drug.

Unattenuated these changes can be 20% or more.

时间窗: 24 hours of total study duration in each case starting from the oral intake of study drug.

次要结局

  • To assess incidence of side effects and complication if any due to study drug(24 hrs in postoperative period after intake of study drug)

研究者

发起方
SIKKIM MANIPAL INSTITUTE OF MEDICAL SCIENCES
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验